|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wood SL, Pernemalm M, Crosbie PA and
Whetton AD: Molecular histology of lung cancer: From targets to
treatments. Cancer Treat Rev. 41:361–375. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang F, Zhang X, Meng J, Zhao Y, Liu X,
Liu Y, Wang Y, Li Y, Sun Y, Wang Z, et al: ING5 inhibits cancer
aggressiveness via preventing EMT and is a potential prognostic
biomarker for lung cancer. Oncotarget. 6:16239–16252. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen X, Song X, Yue W, Chen D, Yu J, Yao Z
and Zhang L: Fibulin-5 inhibits Wnt/β-catenin signaling in lung
cancer. Oncotarget. 6:15022–15034. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Adiseshaiah P, Vaz M, Machireddy N,
Kalvakolanu DV and Reddy SP: A Fra-1-dependent, matrix
metalloproteinase driven EGFR activation promotes human lung
epithelial cell motility and invasion. J Cell Physiol. 216:405–412.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rege TA and Hagood JS: Thy-1 as a
regulator of cell-cell and cell-matrix interactions in axon
regeneration, apoptosis, adhesion, migration, cancer, and fibrosis.
FASEB J. 20:1045–1054. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scognamiglio G, D'Antonio A, Rossi G,
Cavazza A, Camerlingo R, Pirozzi G, La Mantia E, Anniciello AM,
Morabito A, Cantile M, et al: CD90 expression in atypical
meningiomas and meningioma metastasis. Am J Clin Pathol.
141:841–849. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kitayama J, Emoto S, Yamaguchi H, Ishigami
H, Yamashita H, Seto Y, Matsuzaki K and Watanabe T: CD90(+)CD45(−)
intraperitoneal mesothelial-like cells inhibit T cell activation by
production of arginase I. Cell Immunol. 288:8–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ohmura-Kakutani H, Akiyama K, Maishi N,
Ohga N, Hida Y, Kawamoto T, Iida J, Shindoh M, Tsuchiya K,
Shinohara N, et al: Identification of tumor endothelial cells with
high aldehyde dehydrogenase activity and a highly angiogenic
phenotype. PLoS One. 9:e1139102014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma K, Chang D, Gong M, Ding F, Luo A, Tian
F, Liu Z and Wang T: Expression and significance of FRA-1 in
non-small-cell lung cancer. Cancer Invest. 27:353–359. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Adiseshaiah P, Lindner DJ, Kalvakolanu DV
and Reddy SP: FRA-1 proto-oncogene induces lung epithelial cell
invasion and anchorage-independent growth in vitro, but is
insufficient to promote tumor growth in vivo. Cancer Res.
67:6204–6211. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oikonomou D, Hassan K, Kaifi JT, Fiegel
HC, Schurr PG, Reichelt U, Aridome K, Yekebas EF, Mann O, Kluth D,
et al: Thy-1 as a potential novel diagnostic marker for
gastrointestinal stromal tumors. J Cancer Res Clin Oncol.
133:951–955. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang J, Zhang Y, Chuai S, Wang Z, Zheng
D, Xu F, Zhang Y, Li C, Liang Y and Chen Z: Trastuzumab (herceptin)
targets gastric cancer stem cells characterized by CD90 phenotype.
Oncogene. 31:671–682. 2012. View Article : Google Scholar
|
|
14
|
Goldar S, Khaniani MS, Derakhshan SM and
Baradaran B: Molecular mechanisms of apoptosis and roles in cancer
development and treatment. Asian Pac J Cancer Prev. 16:2129–2144.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Paul I and Jones JM: Apoptosis block as a
barrier to effective therapy in non small cell lung cancer. World J
Clin Oncol. 5:588–594. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Beesoo R, Neergheen-Bhujun V, Bhagooli R
and Bahorun T: Apoptosis inducing lead compounds isolated from
marine organisms of potential relevance in cancer treatment. Mutat
Res. 768:84–97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Zhou Y, Wang W, Zheng D, Peng S, Xiong W,
Ma J, Zeng Z, Wu M, Zhou M, Xiang J, et al: Risk of nasopharyngeal
carcinoma associated with polymorphic lactotransferrin haplotypes.
Med Oncol. 29:1456–1462. 2012. View Article : Google Scholar
|
|
19
|
Xiao S, Zhou Y, Yi W, Luo G, Jiang B, Tian
Q, Li Y and Xue M: Fra-1 is downregulated in cervical cancer
tissues and promotes cervical cancer cell apoptosis by p53
signaling pathway in vitro. Int J Oncol. 46:1677–1684.
2015.PubMed/NCBI
|
|
20
|
Zheng D, Liao S, Zhu G, Luo G, Xiao S, He
J, Pei Z, Li G and Zhou Y: CD38 is a putative functional marker for
side population cells in human nasopharyngeal carcinoma cell lines.
Mol Carcinog. Jan 28–2015.Epub ahead of print. View Article : Google Scholar
|
|
21
|
Liao S, Xiao S, Zhu G, Zheng D, He J, Pei
Z, Li G and Zhou Y: CD38 is highly expressed and affects the
PI3K/Akt signaling pathway in cervical cancer. Oncol Rep.
32:2703–2709. 2014.PubMed/NCBI
|
|
22
|
Zhu W, Li J, Su J, Li J, Li J, Deng B, Shi
Q, Zhou Y and Chen X: FOS-like antigen 1 is highly expressed in
human psoriasis tissues and promotes the growth of HaCaT cells in
vitro. Mol Med Rep. 10:2489–2494. 2014.PubMed/NCBI
|
|
23
|
Hara A and Okayasu I: Cyclooxygenase-2 and
inducible nitric oxide synthase expression in human astrocytic
gliomas: Correlation with angiogenesis and prognostic significance.
Acta Neuropathol. 108:43–48. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo M, Alumkal J, Drachova T, Gao D,
Marina SS, Jen J and Herman JG: CHFR methylation strongly
correlates with methylation of DNA damage repair and apoptotic
pathway genes in non-small cell lung cancer. Discov Med.
19:151–158. 2015.PubMed/NCBI
|
|
25
|
Chiu CH, Ho HL, Doong H, Yeh YC, Chen MY,
Chou TY and Tsai CM: MLH1 V384D polymorphism associates with poor
response to EGFR tyrosine kinase inhibitors in patients with EGFR
L858R-positive lung adenocarcinoma. Oncotarget. 6:8407–8417. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Van Nostrand JL, Brisac A, Mello SS,
Jacobs SB, Luong R and Attardi LD: The p53 target gene SIVA enables
non-small cell lung cancer development. Cancer Discov. 5:622–635.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Motrich RD, Castro GM and Caputto BL: Old
players with a newly defined function: Fra-1 and c-Fos support
growth of human malignant breast tumors by activating membrane
biogenesis at the cytoplasm. PLoS One. 8:e532112013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sayan AE, Stanford R, Vickery R,
Grigorenko E, Diesch J, Kulbicki K, Edwards R, Pal R, Greaves P,
Jariel-Encontre I, et al: Fra-1 controls motility of bladder cancer
cells via transcriptional upregulation of the receptor tyrosine
kinase AXL. Oncogene. 31:1493–1503. 2012. View Article : Google Scholar
|
|
29
|
Zhang L, Pan HY, Zhong LP, Wei KJ, Yang X,
Li J, Shen GF and Zhang Z: Fos-related activator-1 is overexpressed
in oral squamous cell carcinoma and associated with tumor lymph
node metastasis. J Oral Pathol Med. 39:470–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Henckels E and Prywes R: Fra-1 regulation
of matrix metallopeptidase-1 (MMP-1) in metastatic variants of
MDA-MB-231 breast cancer cells. F1000Res. 2:2292013.PubMed/NCBI
|
|
31
|
Vial E and Marshall CJ: Elevated ERK-MAP
kinase activity protects the FOS family member FRA-1 against
proteasomal degradation in colon carcinoma cells. J Cell Sci.
116:4957–4963. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Oliveira-Ferrer L, Kürschner M, Labitzky
V, Wicklein D, Müller V, Lüers G, Schumacher U, Milde-Langosch K
and Schröder C: Prognostic impact of transcription factor Fra-1 in
ER-positive breast cancer: Contribution to a metastatic phenotype
through modulation of tumor cell adhesive properties. J Cancer Res
Clin Oncol. 141:1715–1726. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hacker K and Medler KF: Mitochondrial
calcium buffering contributes to the maintenance of Basal calcium
levels in mouse taste cells. J Neurophysiol. 100:2177–2191. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ogura T, Margolskee RF and Kinnamon SC:
Taste receptor cell responses to the bitter stimulus denatonium
involve Ca2+ influx via store-operated channels. J
Neurophysiol. 87:3152–3155. 2002.PubMed/NCBI
|
|
35
|
Akabas M, Dodd J and al-Awqati Q:
Identification of electrophysiologically distinct subpopulations of
rat taste cells. J Membr Biol. 114:71–78. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pulkkinen V, Manson ML, Säfholm J, Adner M
and Dahlén SE: The bitter taste receptor (TAS2R) agonists
denatonium and chloroquine display distinct patterns of relaxation
of the guinea pig trachea. Am J Physiol Lung Cell Mol Physiol.
303:L956–L966. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ruiz-Avila L, McLaughlin SK, Wildman D,
McKinnon PJ, Robichon A, Spickofsky N and Margolskee RF: Coupling
of bitter receptor to phosphodiesterase through transducin in taste
receptor cells. Nature. 376:80–85. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Y, Su X, Wang X, Leung AW, Xu C, Wang P
and Liu Q: Cytotoxic effect of protoporphyrin IX to human leukemia
U937 cells under ultrasonic irradiation. Cell Physiol Biochem.
33:1186–1196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang S and Meyskens FL Jr: Alterations in
activating protein 1 composition correlate with phenotypic
differentiation changes induced by resveratrol in human melanoma.
Mol Pharmacol. 67:298–308. 2005. View Article : Google Scholar
|
|
40
|
Liu KH, Yang ST, Lin YK, Lin JW, Lee YH,
Wang JY, Hu CJ, Lin EY, Chen SM, Then CK, et al: Fluoxetine, an
antidepressant, suppresses glioblastoma by evoking AMPAR-mediated
calcium-dependent apoptosis. Oncotarget. 6:5088–5101. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chumakov PM: Function of the p53 gene:
Choice between life and death. Biochemistry (Mosc). 65:28–40.
2000.
|
|
42
|
Chipuk JE and Green DR: Dissecting
p53-dependent apoptosis. Cell Death Differ. 13:994–1002. 2006.
View Article : Google Scholar : PubMed/NCBI
|
